A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...
“A new era in genetic testing has arrived,” said Carlos Bustamante, Ph.D., CEO & Co-Founder, Galatea Bio. “StrataRisk PRS empowers clinical genetic labs to deliver more informative reports to ...
As cancer rates rise in younger adults, Eyewitness News has compiled a list of resources to help assess your risk of cancer ...
Carson City Justice of the Peace Melanie Bruketta on Friday denied a motion to increase bail but approved additional ...
A study in Cancer compared the accuracy of five risk scores for time to treatment in CLL, including the IPS-E, CR0, AIPS-E, ...
Senior digital leaders have revealed that a mechanism introduced in 2023 to consider the dangers of ageing tech in government ...
Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a study published in JAMA Network Open.
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...
The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback